Case Study

“Disrupting the perfect” - A leader’s quest to future-proof Novo Nordisk

19 pages
May 2026
Reference: IMD-2766

In the years before its dramatic rise on the back of GLP-1 therapies, Novo Nordisk was best known for disciplined execution, a strong focus on diabetes and a long record of home-grown innovation. It met its targets with near predictable consistency, supported by stable structures and deeply embedded ways of working. Yet technological change, scientific uncertainty and increasing market pressures challenged whether a model built on reliability and internal self-sufficiency could keep pace. This case examines how Marcus Schindler, an externally hired leader who would later become the company’s Chief Scientific Officer, attempted to future-proof Novo Nordisk’s research and development organization. Rather than relying on incremental improvements, he introduced ambitious aspirations, pushed teams to experiment beyond their comfort zones, normalized failure as a source of learning and tested new organizational structures alongside the existing core. As students follow these choices, the case exposes a set of concrete leadership dilemmas: How fast should a leader push change in a stable, successful organization? How do you gain credibility as an outsider without full consensus? How do you balance accountability and psychological safety? And how do you allocate attention between short-term execution and long-term renewal? The dilemma becomes sharper as Novo Nordisk’s GLP-1 therapies deliver extraordinary commercial success, shifting focus toward operational execution and raising questions about whether exploration risks being crowded out by exploitation. A deeper leadership question also emerges: How does a leader stay true to a long-term vision when runaway success pulls attention toward the here and now? This case challenges readers to think critically about leading change in high-performing organizations, driving transformational innovation, managing competing time horizons, and making leadership choices when success itself becomes the biggest constraint.

Learning Objective
  • Analyze the dynamics of leading change in an entrenched organizational culture.
  • Evaluate the role of enterprise-wide innovation initiatives in cultural transformation.
  • Evaluate how leaders cultivate a culture of psychological safety and failure tolerance and assess the personal and organizational conditions that either enable or constrain such a culture.
  • Analyze the tradeoffs between exploration and exploitation and assess how leaders allocate attention and resources across competing short-term and long-term priorities.
  • Critically assess the limits of purpose-driven leadership within constrained organizational environments.
Keywords
Leadership, Strategy, Change Management, Innovation, Organizational Transformation, Psychological Safety, Future-proofing, Purpose
Settings
World/global, Denmark
Novo Nordisk, Healthcare, Pharmaceuticals
2017-2024
Type
Field Research
Copyright
© 2026
Available Languages
English
Related material
Teaching note
Case clearing houses
IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Discover our latest research
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics